Literature DB >> 3970470

Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease.

S C Textor, A C Novick, R C Tarazi, V Klimas, D G Vidt, M Pohl.   

Abstract

We studied renal plasma flow and glomerular filtration rate during graded blood pressure reduction induced with sodium nitroprusside infusion in 16 hypertensive patients with atherosclerotic renovascular disease. Eight patients with unilateral disease tolerated pressure reduction from 205 +/- 9 (SE)/103 +/- 2 mm Hg to 146 +/- 6/84 +/- 3 mm Hg (p less than 0.01) with no change in total renal function. In 8 other patients with bilateral renal arterial stenosis (all arteries 70% or more stenosed), similar pressure reduction produced marked but reversible decrements in plasma flow (152 +/- 28 mL/min to 66 +/- 13 mL/min; p less than 0.01) and glomerular filtration rate (38 +/- 8 mL/min to 16 +/- mL/min; p less than 0.01). In 4 patients restudied after revascularization, sensitivity of renal function to pressure changes was no longer present. These data indicate that vascular stenosis to the entire renal mass may limit function and provide a means for evaluating patients at risk for loss of renal function during antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970470     DOI: 10.7326/0003-4819-102-3-308

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

Review 1.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

2.  Hypertension and reduced renal function in an 83-year-old patient.

Authors:  Andrea Ungar; Lorella Lambertucci; Chiara Agresti; Riccardo Pini; Maria Boddi; Maria Consuelo Valentini; Gianfranco Parati; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  ACE inhibitors in renovascular hypertension.

Authors:  S C Textor
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 4.  Atherosclerotic renal artery stenosis: from diagnosis to treatment.

Authors:  P Carmichael; A R Carmichael
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

5.  [Transluminal dilatation and other nonsurgical catheter technics in the treatment of renovascular hypertension].

Authors:  P Grützmacher; W D Bussmann
Journal:  Klin Wochenschr       Date:  1986-09-15

Review 6.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

7.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

8.  Renal Artery Stenosis.

Authors:  Stephen C. Textor; Michael A. McKusick
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

Review 9.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.